Randomized clinical trial of mitomycin c as an adjunct to radiotherapy in head and neck cancer
โ Scribed by Joseph B. Weissberg; Yung H. Son; Rose J. Papac; Clarence Sasaki; Diana B. Fischer; Roberta Lawrence; Sara Rockwell; Alan C. Sartorelli; James J. Fischer
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 869 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The purpose of this study was to determine the efficacy of mitomycin C as an adjunct to radiotherapy for the treatment of locally advanced cervix cancer. Patients with squamous-cell carcinoma of the cervix, stages IB2-IVA, were randomized to receive radiotherapy alone or radiotherapy with concomitan
## Background: We aimed to determine the effect of dietary counseling or oral supplements on outcome for patients with cancer, specifically, nutritional outcome, morbidity, and quality of life (qol), during and 3 months after radiotherapy. ## Methods: Seventy-five patients with head and neck canc
Background. Treating the neck after organpreservation treatment with radiotherapy or chemoradiotherapy can be problematic. Methods. To develop management guidelines, we reviewed the results of a 100-patient phase-3 trial that had compared outcome after radiotherapy alone with outcome after chemorad
Background. This study investigated the individual and collective (''community'') equipoise of surgeons and oncologists and their willingness to take part in each of six hypothetical randomized controlled trials in head and neck oncology. Methods. A survey was mailed to Australasian head and neck s